Personally, I don't care ...

Personally, I don't care what anyone says. I know everyone who had Dr.Curry is extremely happy . We trust him as a man and Doctor. I wouldn't be at all interested in ever going to Brazil or Mexico. I want to be near my Doc. Excuse me for not being at all interested in the DS and believe me I would still refer anyone who needs it, RNY to Doctor Curry in a New York minute.

So, instead of answering my very calm and reasonable post stating facts about your questions about diabetes you start a new thread to continue your complaining. I get the picture. Nobody said Dr. Curry's patients weren't happy with him, nobody is forcing you to Mexico or Brazil and I'm sorry you aren't interested in advances in medicine that could benefit a lot of people. I guess back in the old days there were people that didn't want to give up bleeding and leeches as medicinal treatment also. Terri

Cindy, I agree with you completely, but probably best to ignore them. They are having a grand ol' time on their board slamming everyone on the Ohio board...laughing it up and encouraging each other to post on this board while copying your comments to their posts. I wish them all luck in their individual persuits, but they need to all take a chill.

Ignore us....see if I care....and keep taking your diabetes meds.....I've been around long enough to know that some of you are a lost cause......but when one of my sisters is called "nuts," I'll be damned if I'll sit by idly and say nothing! LeaAnn

you are all boring to me.

Snappy Comeback..... did they teach that to you in Kindergarten......they taught my children manners! kevin

I am so happy yoiu a cure for diabetes. You are NUTS if you believe that. It seems like you are brainwashed.

Oh, yeah...okay, brainwashed by all the post-op DSers that testify to going off their meds within DAYS after having surgery. Brainwashed by all those LIARS that talk about how their symptoms are GONE, never to return EVEN IF THEY EAT SUGAR!. Brainwashed by the lies in the medical literature! DAMN, those LIARS for brainwashing me!! I guess they all must be a bunch of LIE-TELLING NUTS to believe that their diabetes has been cured! But you haven't even read these testimonials or the literature, so, again, what do YOU know? LeaAnn

Nobody had to brainwash me into not taking insulin since the day I had my surgery- I just simply took my doctors and surgeons word for it and looked at my numbers- I think a blood sugar of 80 average is good enough for me!!! I can read my own meter- nobody has to BRAINWASH me!

I Europe it has become an accepted treatment for diabeties. They do the DS with out the gastric restriction to CURE diabeties. Here is some of the info on the issue!! From PubMed (this seems VERY conservatively stated, by the way): Obes Surg. 2004 Nov-Dec;14(10):1354-9 Duodenal switch without gastric resection: results and observations after 6 years. Cossu ML, Noya G, Tonolo GC, Profili S, Meloni GB, Ruggiu M, Brizzi P, Cossu F, Pilo L, Tilocca PL. Centro di Chirurgia Generale e Della Grande Obesita', Policlinico Universitario, Italy. [email protected] BACKGROUND: The results on metabolic effects of the classical biliopancreatic diversion (BPD) have led us to investigate the operation without gastric resection, thus preserving stomach and pylorus, in patients who are not seriously obese but suffer from hypercholesterolemia, often associated with type 2 diabetes and hypertriglyceridemia. METHODS: Between 1996 and 1999, we performed the duodenal switch (DS) without gastric resection on 24 mildly obese patients. Mean preoperative BMI was 36.2 kg/m(2). 17 patients (70.8%) suffered from type 1 diabetes, 4 (16.6%) had impaired glucose tolerance, while the remainder had fasting hyperglycemia. In 20 patients (83.3%), hypercholesterolemia and alterations in lipid profile were present. Another 20 patients were taking drugs for arterial hypertension. The pluri-metabolic syndrome was present in 41.6% of patients. RESULTS: Mean follow-up was 4 years. BMI reduction and weight loss were not large. 2 patients who had severe longstanding diabetes type 2 needed a second operation of the classical BPD because of failure in improving diabetes. Another 2 patients were changed to classical BPD because of a relapsing chronic duodeno-ileal ulcer. The incidence of ileal ulcer was 29.1%. Regarding hypercholesterolemia, hypertrigliceridemia, and type 2 diabetes when there is a good pancreatic "reservoir", the operation seems effective in the long-term. Protein absorption is better than that obtained with the classical BPD. CONCLUSIONS: Our long-term results suggest that in carefully selected patients suffering from serious hypercholesterolemia or type 2 diabetes with insulin reserves still at an acceptable level, and with BMI 30-40, DS without gastric resection can be proposed as a surgical treatment for metabolic diseases but not for obesity. ******************************************* Obes Surg. 2001 Oct;11(5):635-9 Improvement of weight loss and metabolic effects of vertical banded gastroplasty by an added duodenal switch procedure. Yashkov YI, Oppel TA, Shishlo LA, Vinnitsky LI. Dept. of Liver, Bile Ducts and Pancreatic Surgery, Russian Research Center of Surgery RAMS, Moscow, Russia. [email protected] BACKGROUND: Some patients who underwent vertical banded gastroplasty (VBG) need revisional operations because of poor weight loss and remaining comorbidities. The duodenal switch (DS) procedure with partial gastrectomy is known as an effective method for treatment of severe obesity and related dyslipoproteinemias and diabetes mellitus type 2 (DM2). Other investigations have shown that DS without gastric resection similarly corrects hypercholesterolemia and DM2 in the "less than" morbidly obese patients. METHODS: Based on this knowledge, we performed a DS simultaneously with hernioplasty and panniculectomy in a 63-year-old woman with a fair EWL (36.4%), with remaining hypercholesterolemia and DM2 4 years after VBG. The pouch stoma diameter was 13 mm, and there was no pouch dilation nor staple-line disruption. The previously partitioned stomach was left in place. H2-blockers and polyvitamins were prescribed after operation. RESULTS: 1 year after DS there were no postoperative complications and undesirable effects except slight anemia. DS allowed improvement in weight loss, improved carbohydrate handling without need for insulin or other hypoglycemic agents, and corrected severe hypercholesterolemia. CONCLUSION: DS per se in the case presented had a decisive effect on DM2 and hypercholesterolemia. DS should be kept in mind as a second-step malabsorptive procedure after a failed purely restrictive operation. Potential of surgery for curing type 2 diabetes mellitus. Rubino F, Gagner M. IRCAD-European Institute of Telesurgery, Strasbourg, France. [email protected] OBJECTIVE: To review the effect of morbid obesity surgery on type 2 diabetes mellitus, and to analyze data that might explain the mechanisms of action of these surgeries and that could answer the question of whether surgery for morbid obesity can represent a cure for type 2 diabetes in nonobese patients as well. SUMMARY BACKGROUND DATA: Diabetes mellitus type 2 affects more than 150 million people worldwide. Although the incidence of complications of type 2 diabetes can be reduced with tight control of hyperglycemia, current therapies do not achieve a cure. Some operations for morbid obesity not only induce significant and lasting weight loss but also lead to improvements in or resolution of comorbid disease states, especially type 2 diabetes. METHODS: The authors reviewed data from the literature to address what is known about the effect of surgery for obesity on glucose metabolism and the endocrine changes that follow this surgery. RESULTS: Series with long-term follow-up show that gastric bypass and biliopancreatic diversion achieve durable normal levels of plasma glucose, plasma insulin, and glycosylated hemoglobin in 80% to 100% of severely obese diabetic patients, usually within days after surgery. Available data show a significant change in the pattern of secretion of gastrointestinal hormones. Case reports have also documented remission of type 2 diabetes in nonmorbidly obese individuals undergoing biliopancreatic diversion for other indications. CONCLUSIONS: Gastric bypass and biliopancreatic diversion seem to achieve control of diabetes as a primary and independent effect, not secondary to the treatment of overweight. Although controlled trials are needed to verify the effectiveness on nonobese individuals, gastric bypass surgery has the potential to change the current concepts of the pathophysiology of type 2 diabetes and, possibly, the management of this disease. Publication Types: Review PMID: 12409659 [PubMed - indexed for MEDLINE] ___________________________________________________________ 1: Treat Endocrinol. 2005;4(1):55-64. Related Articles, Links Surgical management of obesity: a review of the evidence relating to the health benefits and risks. Lara MD, Kothari SN, Sugerman HJ. Department of General and Vascular Surgery, Gundersen Lutheran Medical Center, LaCrosse, Wisconsin 54601, USA. Obesity continues to plague our society in epidemic proportions. Surgery for morbid obesity is considered by many as the most effective therapy for this complex disorder. Today, multiple surgical procedures for the treatment of obesity are available. As with most procedures, there are benefits and risks associated with open and laparoscopic gastric bypass surgery, as well as with laparoscopic adjustable gastric banding and partial biliopancreatic bypass with a duodenal switch. The risks and complications associated with bariatric surgery may be serious and in some cases life threatening. However, surgery for obesity has shown remarkable results in helping patients to achieve significant long-term weight control. In addition, it is associated with improvement and often resolution of co-morbid conditions, including type 2 diabetes mellitus, systemic hypertension, obesity hypoventilation, sleep apnea, venous stasis disease, pseudotumor cerebri, polycystic ovary syndrome, complications of pregnancy and delivery, gastroesophageal reflux disease, stress urinary incontinence, degenerative joint disease, and non-alcoholic steatohepatitis. Publication Types: * Review * Review, Tutorial PMID: 15649101 [PubMed - indexed for MEDLINE] _____________________________________________________________ 1: Obes Surg. 2004 Nov-Dec;14(10):1354-9. Related Articles, Links Click here to read Duodenal switch without gastric resection: results and observations after 6 years. Cossu ML, Noya G, Tonolo GC, Profili S, Meloni GB, Ruggiu M, Brizzi P, Cossu F, Pilo L, Tilocca PL. Centro di Chirurgia Generale e Della Grande Obesita', Policlinico Universitario, Italy. [email protected] BACKGROUND: The results on metabolic effects of the classical biliopancreatic diversion (BPD) have led us to investigate the operation without gastric resection, thus preserving stomach and pylorus, in patients who are not seriously obese but suffer from hypercholesterolemia, often associated with type 2 diabetes and hypertriglyceridemia. METHODS: Between 1996 and 1999, we performed the duodenal switch (DS) without gastric resection on 24 mildly obese patients. Mean preoperative BMI was 36.2 kg/m(2). 17 patients (70.8%) suffered from type 1 diabetes, 4 (16.6%) had impaired glucose tolerance, while the remainder had fasting hyperglycemia. In 20 patients (83.3%), hypercholesterolemia and alterations in lipid profile were present. Another 20 patients were taking drugs for arterial hypertension. The pluri-metabolic syndrome was present in 41.6% of patients. RESULTS: Mean follow-up was 4 years. BMI reduction and weight loss were not large. 2 patients who had severe longstanding diabetes type 2 needed a second operation of the classical BPD because of failure in improving diabetes. Another 2 patients were changed to classical BPD because of a relapsing chronic duodeno-ileal ulcer. The incidence of ileal ulcer was 29.1%. Regarding hypercholesterolemia, hypertrigliceridemia, and type 2 diabetes when there is a good pancreatic "reservoir", the operation seems effective in the long-term. Protein absorption is better than that obtained with the classical BPD. CONCLUSIONS: Our long-term results suggest that in carefully selected patients suffering from serious hypercholesterolemia or type 2 diabetes with insulin reserves still at an acceptable level, and with BMI 30-40, DS without gastric resection can be proposed as a surgical treatment for metabolic diseases but not for obesity. PMID: 15603651 [PubMed - indexed for MEDLINE] _______________________________________________________ 1: JAMA. 2004 Oct 13;292(14):1724-37. Related Articles, Links Erratum in: * JAMA. 2005 Apr 13;293(14):1728. Comment in: * JAMA. 2005 Apr 13;293(14):1726; author reply 1726. * JAMA. 2005 Apr 13;293(14):1726; author reply 1726. Click here to read Bariatric surgery: a systematic review and meta-analysis. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Department of Surgery, University of Minnesota, Minneapolis 55455, USA. [email protected] CONTEXT: About 5% of the US population is morbidly obese. This disease remains largely refractory to diet and drug therapy, but generally responds well to bariatric surgery. OBJECTIVE: To determine the impact of bariatric surgery on weight loss, operative mortality outcome, and 4 obesity comorbidities (diabetes, hyperlipidemia, hypertension, and obstructive sleep apnea). DATA SOURCES AND STUDY SELECTION: Electronic literature search of MEDLINE, Current Contents, and the Cochrane Library databases plus manual reference checks of all articles on bariatric surgery published in the English language between 1990 and 2003. Two levels of screening were used on 2738 citations. DATA EXTRACTION: A total of 136 fully extracted studies, whi*****luded 91 overlapping patient populations (kin studies), were included for a total of 22,094 patients. Nineteen percent of the patients were men and 72.6% were women, with a mean age of 39 years (range, 16-64 years). Sex was not reported for 1537 patients (8%). The baseline mean body mass index for 16 944 patients was 46.9 (range, 32.3-68.8). DATA SYNTHESIS: A random effects model was used in the meta-analysis. The mean (95% confidence interval) percentage of excess weight loss was 61.2% (58.1%-64.4%) for all patients; 47.5% (40.7%-54.2%) for patients who underwent gastric banding; 61.6% (56.7%-66.5%), gastric bypass; 68.2% (61.5%-74.8%), gastroplasty; and 70.1% (66.3%-73.9%), biliopancreatic diversion or duodenal switch. Operative mortality (< or =30 days) in the extracted studies was 0.1% for the purely restrictive procedures, 0.5% for gastric bypass, and 1.1% for biliopancreatic diversion or duodenal switch. Diabetes was completely resolved in 76.8% of patients and resolved or improved in 86.0%. Hyperlipidemia improved in 70% or more of patients. Hypertension was resolved in 61.7% of patients and resolved or improved in 78.5%. Obstructive sleep apnea was resolved in 85.7% of patients and was resolved or improved in 83.6% of patients. CONCLUSIONS: Effective weight loss was achieved in morbidly obese patients after undergoing bariatric surgery. A substantial majority of patients with diabetes, hyperlipidemia, hypertension, and obstructive sleep apnea experienced complete resolution or improvement. Publication Types: * Meta-Analysis * Review PMID: 15479938 [PubMed - indexed for MEDLINE] ________________________________________________________________ 1: Obes Surg. 1998 Jun;8(3):267-82. Related Articles, Links Click here to read Biliopancreatic diversion with a duodenal switch. Hess DS, Hess DW. Wood County Hospital, Bowling Green, OH, USA. BACKGROUND: This paper evaluates biliopancreatic diversion combined with the duodenal switch, forming a hybrid procedure which is a combination of restriction and malabsorption. METHODS: The evaluation is of the first 440 patients undergoing this procedure who had had no previous bariatric surgery. The mean starting weight was 183 kg, with 41% of our patients considered super morbidly obese (BMI > 50). RESULTS: There was an average maximum weight loss of 80% excess weight by 24 months postoperation; this continued at a 70% level for 8 years. Major complications were found in almost 9% of the cases. There were two perioperative deaths, one from pulmonary embolism and one from acute pulmonary obstruction. There were 36 type II diabetics, all of whom have discontinued medication following the surgery. Seventeen revisions were performed to correct excess weight loss and low protein levels. There have been no marginal ulcers, no cases of dumping syndrome, no foreign material used, and the procedure is a pyloric saving procedure which is functionally reversible. CONCLUSIONS: This operation has vastly improved the lives of seriously obese patients with many comorbidities. All type II diabetics have essentially been cured of their disease. The procedure was tolerated well and patients are quite satisfied. There was minimal regain of weight with this method. PMID: 9678194 [PubMed - indexed for MEDLINE]